DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

13.58 -0.27 (-1.95%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VNDA $13.58 -1.95%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.72
Previous Close $13.85
Daily Range $13.31 - $14.25
52-Week Range $4.46 - $19.25
Market Cap $455.0M
P/E Ratio -20.27
Dividend (Yield) $0.00 (0.0%)
Volume 904,063
Average Daily Volume 1,323,284
Current FY EPS -$1.29





Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website:

News & Commentary Rss Feed

Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape

Vanda Pharmaceuticals (VNDA) In A Perilous Reversal

Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High

Vanda Reports Wider-than-Expected Loss - Analyst Blog

Vanda Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript

Vanda Pharmaceuticals' Q4 Loss Widens on Higher Expenses

Vanda Pharmaceuticals reduced R&D expenses by 41%, but a tripling in SG&A expenses combined with modest Fanapt growth caused its loss to widen by 20%.

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Short Interest Drops 15.5% For VNDA

Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming

3 Horrendous Health-Care Stocks This Week

Which health-care stocks had as lousy of a week as Broncos fans? Here are 3 big losers from the past few days.

See More VNDA News...

VNDA's Top Competitors

VNDA $13.58 (-1.95%)
Current stock: VNDA
GILD $70.00 (1.04%)
Current stock: GILD
AMGN $115.46 (-0.07%)
Current stock: AMGN
BIIB $290.54 (-0.32%)
Current stock: BIIB